Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Elantan SR vs Imdur SR in Healthy Korean Males
NCT02101710Phase 1Completed
- Sponsor
- UCB
- Start
- Jun 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of isosorbide mononitrate in angina pectoris (4 arms), sponsored by UCB. Primary endpoints: Area Under the Concentration-time Curve from time Baseline to the Last Quantifiable point at 36 hours and Maximum Observed Plasma Concentration at 36 hours. Started Jun 2011; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT02101710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101710.